• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SENP3 介导的宿主防御反应包含 HBV 复制并恢复蛋白质合成。

SENP3-mediated host defense response contains HBV replication and restores protein synthesis.

机构信息

Department of Biomedical Engineering, Pratt School of Engineering, Duke University, Durham, North Carolina, United States of America.

Duke Center for Genomic and Computational Biology, Duke University, Durham, North Carolina, United States of America.

出版信息

PLoS One. 2019 Jan 14;14(1):e0209179. doi: 10.1371/journal.pone.0209179. eCollection 2019.

DOI:10.1371/journal.pone.0209179
PMID:30640896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6331149/
Abstract

Certain organs are capable of containing the replication of various types of viruses. In the liver, infection of Hepatitis B virus (HBV), the etiological factor of Hepatitis B and hepatocellular carcinoma (HCC), often remains asymptomatic and leads to a chronic carrier state. Here we investigated how hepatocytes contain HBV replication and promote their own survival by orchestrating a translational defense mechanism via the stress-sensitive SUMO-2/3-specific peptidase SENP3. We found that SENP3 expression level decreased in HBV-infected hepatocytes in various models including HepG2-NTCP cell lines and a humanized mouse model. Downregulation of SENP3 reduced HBV replication and boosted host protein translation. We also discovered that IQGAP2, a Ras GTPase-activating-like protein, is a key substrate for SENP3-mediated de-SUMOylation. Downregulation of SENP3 in HBV infected cells facilitated IQGAP2 SUMOylation and degradation, which leads to suppression of HBV gene expression and restoration of global translation of host genes via modulation of AKT phosphorylation. Thus, The SENP3-IQGAP2 de-SUMOylation axis is a host defense mechanism of hepatocytes that restores host protein translation and suppresses HBV gene expression.

摘要

某些器官能够控制各种类型病毒的复制。在肝脏中,乙型肝炎病毒(HBV)的感染——乙型肝炎和肝细胞癌(HCC)的病因,通常无症状,并导致慢性携带者状态。在这里,我们研究了肝细胞如何通过应激敏感的 SUMO-2/3 特异性肽酶 SENP3 协调翻译防御机制来包含 HBV 复制并促进自身存活。我们发现,在 HepG2-NTCP 细胞系和人源化小鼠模型等各种模型中,HBV 感染的肝细胞中的 SENP3 表达水平降低。SENP3 的下调减少了 HBV 的复制并促进了宿主蛋白的翻译。我们还发现,IQGAP2,一种 Ras GTPase 激活样蛋白,是 SENP3 介导的去 SUMO 化的关键底物。HBV 感染细胞中 SENP3 的下调促进了 IQGAP2 的 SUMO 化和降解,这导致通过调节 AKT 磷酸化来抑制 HBV 基因表达和恢复宿主基因的整体翻译。因此,SENP3-IQGAP2 去 SUMO 化轴是肝细胞的宿主防御机制,它恢复宿主蛋白的翻译并抑制 HBV 基因的表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/6331149/cbc74a7afcde/pone.0209179.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/6331149/edddbdd248cc/pone.0209179.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/6331149/564ef1a022a0/pone.0209179.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/6331149/6876d857fe52/pone.0209179.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/6331149/fead6caff50b/pone.0209179.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/6331149/e5b838df62ce/pone.0209179.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/6331149/0c01faccb669/pone.0209179.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/6331149/02fc02994664/pone.0209179.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/6331149/cbc74a7afcde/pone.0209179.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/6331149/edddbdd248cc/pone.0209179.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/6331149/564ef1a022a0/pone.0209179.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/6331149/6876d857fe52/pone.0209179.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/6331149/fead6caff50b/pone.0209179.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/6331149/e5b838df62ce/pone.0209179.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/6331149/0c01faccb669/pone.0209179.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/6331149/02fc02994664/pone.0209179.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9e3/6331149/cbc74a7afcde/pone.0209179.g008.jpg

相似文献

1
SENP3-mediated host defense response contains HBV replication and restores protein synthesis.SENP3 介导的宿主防御反应包含 HBV 复制并恢复蛋白质合成。
PLoS One. 2019 Jan 14;14(1):e0209179. doi: 10.1371/journal.pone.0209179. eCollection 2019.
2
Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.乙型肝炎病毒感染和复制的稳健人源和鼠源肝细胞培养模型。
J Virol. 2018 Nov 12;92(23). doi: 10.1128/JVI.01255-18. Print 2018 Dec 1.
3
Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection.在增殖的肝细胞中下调细胞膜定位的 NTCP 表达可预防乙型肝炎病毒感染。
Emerg Microbes Infect. 2019;8(1):879-894. doi: 10.1080/22221751.2019.1625728.
4
DOCK11 and DENND2A play pivotal roles in the maintenance of hepatitis B virus in host cells.DOCK11 和 DENND2A 在宿主细胞中维持乙型肝炎病毒方面发挥着关键作用。
PLoS One. 2021 Feb 4;16(2):e0246313. doi: 10.1371/journal.pone.0246313. eCollection 2021.
5
Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication.乙型肝炎病毒X蛋白促进SMC5/6降解以增强乙肝病毒复制。
Cell Rep. 2016 Sep 13;16(11):2846-2854. doi: 10.1016/j.celrep.2016.08.026.
6
Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype.乙型肝炎病毒使细胞周期失调控以促进病毒复制和癌前表型。
J Virol. 2018 Sep 12;92(19). doi: 10.1128/JVI.00722-18. Print 2018 Oct 1.
7
Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.乙型肝炎病毒和丙型肝炎病毒在 Huh-7 细胞中的相互作用。
J Hepatol. 2009 Sep;51(3):446-57. doi: 10.1016/j.jhep.2009.04.025. Epub 2009 Jun 3.
8
The hepatitis B virus (HBV) HBx protein activates AKT to simultaneously regulate HBV replication and hepatocyte survival.乙肝病毒(HBV)的X蛋白激活AKT,以同时调节HBV复制和肝细胞存活。
J Virol. 2015 Jan 15;89(2):999-1012. doi: 10.1128/JVI.02440-14. Epub 2014 Oct 29.
9
Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.乙型肝炎和丁型肝炎病毒利用牛磺胆酸钠共转运多肽进行种属特异性进入肝细胞。
Gastroenterology. 2014 Apr;146(4):1070-83. doi: 10.1053/j.gastro.2013.12.024. Epub 2013 Dec 19.
10
Hepatitis B virus modulates store-operated calcium entry to enhance viral replication in primary hepatocytes.乙型肝炎病毒调节钙库操纵的钙内流以增强原代肝细胞中的病毒复制。
PLoS One. 2017 Feb 2;12(2):e0168328. doi: 10.1371/journal.pone.0168328. eCollection 2017.

引用本文的文献

1
TRIM28 functions as SUMO ligase to SUMOylate TRAF6 and regulate NF-κB activation in HBV-replicating cells.TRIM28作为一种SUMO连接酶,对TRAF6进行SUMO化修饰,并调节乙肝病毒复制细胞中NF-κB的激活。
Hepatol Int. 2025 Feb 7. doi: 10.1007/s12072-025-10779-6.
2
Identification of Host Proteins Involved in Hepatitis B Virus Genome Packaging.鉴定参与乙型肝炎病毒基因组包装的宿主蛋白。
J Proteome Res. 2024 Sep 6;23(9):4128-4138. doi: 10.1021/acs.jproteome.4c00505. Epub 2024 Jul 30.
3
Abnormal protein SUMOylation in liver disease: novel target for therapy.

本文引用的文献

1
Simple and Reliable Method to Quantify the Hepatitis B Viral Load and Replicative Capacity in Liver Tissue and Blood Leukocytes.定量肝组织和血液白细胞中乙肝病毒载量及复制能力的简单可靠方法。
Hepat Mon. 2016 Feb 29;16(10):e28751. doi: 10.5812/hepatmon.28751. eCollection 2016 Oct.
2
Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication.乙型肝炎病毒X蛋白促进SMC5/6降解以增强乙肝病毒复制。
Cell Rep. 2016 Sep 13;16(11):2846-2854. doi: 10.1016/j.celrep.2016.08.026.
3
IQGAP2 is a novel interferon-alpha antiviral effector gene acting non-conventionally through the NF-κB pathway.
肝脏疾病中异常的蛋白质 SUMOylation:治疗的新靶点。
J Mol Med (Berl). 2024 Jun;102(6):719-731. doi: 10.1007/s00109-024-02440-w. Epub 2024 Apr 3.
4
Epigenetic basis of oncogenic-Kras-mediated epithelial-cellular proliferation and plasticity.致癌性Kras介导的上皮细胞增殖和可塑性的表观遗传基础。
Dev Cell. 2022 Feb 7;57(3):310-328.e9. doi: 10.1016/j.devcel.2022.01.006.
5
SUMOylation in Viral Replication and Antiviral Defense.SUMOylation 在病毒复制和抗病毒防御中的作用。
Adv Sci (Weinh). 2022 Mar;9(7):e2104126. doi: 10.1002/advs.202104126. Epub 2022 Jan 21.
6
The Role of Protein SUMOylation in Human Hepatocellular Carcinoma: A Potential Target of New Drug Discovery and Development.蛋白质SUMO化修饰在人类肝细胞癌中的作用:新药发现与开发的潜在靶点
Cancers (Basel). 2021 Nov 14;13(22):5700. doi: 10.3390/cancers13225700.
7
Combined identification of , , and as effective prognostic biomarkers for hepatocellular carcinoma.联合鉴定、、和作为肝细胞癌的有效预后生物标志物。
Aging (Albany NY). 2021 Feb 7;13(3):4696-4712. doi: 10.18632/aging.202586.
8
The Critical Roles of the SUMO-Specific Protease SENP3 in Human Diseases and Clinical Implications.小泛素样修饰特异性蛋白酶SENP3在人类疾病中的关键作用及临床意义
Front Physiol. 2020 Oct 30;11:558220. doi: 10.3389/fphys.2020.558220. eCollection 2020.
IQGAP2是一种新型的干扰素α抗病毒效应基因,通过非传统方式经由核因子κB途径发挥作用。
J Hepatol. 2016 Nov;65(5):972-979. doi: 10.1016/j.jhep.2016.06.028. Epub 2016 Jul 9.
4
[MOLECULAR BIOLOGY OF HEPATITIS B VIRUS AND IMMUNOPATHOGENESIS OF CHRONIC VIRAL HEPATITIS B].[乙型肝炎病毒的分子生物学与慢性乙型病毒性肝炎的免疫发病机制]
Zh Mikrobiol Epidemiol Immunobiol. 2016 Mar-Apr(2):119-26.
5
Mechanisms of HBV-induced hepatocellular carcinoma.HBV 诱导肝细胞癌的机制。
J Hepatol. 2016 Apr;64(1 Suppl):S84-S101. doi: 10.1016/j.jhep.2016.02.021.
6
Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor.乙型肝炎病毒 X 蛋白将 Smc5/6 复合物鉴定为宿主限制因子。
Nature. 2016 Mar 17;531(7594):386-9. doi: 10.1038/nature17170.
7
Hepatitis B "e" antigen-mediated inhibition of HBV replication fitness and transcription efficiency in vitro.乙肝“e”抗原在体外介导对乙肝病毒复制适应性和转录效率的抑制作用。
Virology. 2015 Oct;484:234-240. doi: 10.1016/j.virol.2015.06.011. Epub 2015 Jun 25.
8
IQ Motif-Containing GTPase-Activating Protein 2 (IQGAP2) Is a Novel Regulator of Colonic Inflammation in Mice.含IQ模体的GTP酶激活蛋白2(IQGAP2)是小鼠结肠炎症的新型调节因子。
PLoS One. 2015 Jun 5;10(6):e0129314. doi: 10.1371/journal.pone.0129314. eCollection 2015.
9
Advances in the development of SUMO specific protease (SENP) inhibitors.SUMO特异性蛋白酶(SENP)抑制剂的研发进展。
Comput Struct Biotechnol J. 2015 Mar 24;13:204-11. doi: 10.1016/j.csbj.2015.03.001. eCollection 2015.
10
Molecular biology of hepatitis B virus infection.乙型肝炎病毒感染的分子生物学
Virology. 2015 May;479-480:672-86. doi: 10.1016/j.virol.2015.02.031. Epub 2015 Mar 7.